News and Views

The study from the lab of Professor Howard Petrie points to a mechanism by which antioxidants in the diet could slow atrophy of the thymus.

New research from the Janda lab shows a bacterial enzyme that degrades nicotine possesses promising characteristics for drug development.

A single injection of the drug candidate from the Miller lab prevents meth relapse in animal models.

Associate Professor Douglas Kojetin will lead the new four-year study.

Meet the newest member of Career and Postdoctoral Services team at Scripps Florida.

Technology Meets Teamwork: Andrew Ward Unlocks Viruses’ Secrets
Team Finds New Antibody Weapons against Marburg Virus
Scientists Pinpoint Mechanism for Altered Pattern of Brain Growth in Autism Spectrum Disorder
TSRI-Designed Drug Candidate Significantly Reduces HIV Reactivation Rate
Chemists Find Efficient, Scalable Way to Synthesize Potential Brain-Protecting Compound
AIDS Vaccine Candidate Successfully ‘Primes’ Immune System
Scientists Identify a Potential New Treatment for Osteoporosis
New Close-Up View Reveals Key Part of Ebola Virus Life Cycle
Team Shows Antitumor Agent Can Be Activated by Natural Response to Cell Stress
Study: Hormone ‘Erases’ Male Smell for Female Mice
Modern Alchemy: Chemists Devise Synthesis of Valuable Exotic Compounds
TSRI Celebrates 23rd Commencement
Scientists Find Hyped New Recreational Drug ‘Flakka’ Is As Addictive As 'Bath Salts'
Study Finds Metabolic Link Between Bacterial ‘Biofilms’ and Colon Cancer
New Study: Nerve Cells and Blood Vessels in Eye ‘Talk’ to Prevent Disease